| Application | Recommended Dilution |
|---|---|
| ELISA | 1:5000-1:50000 |
VSIR, also known as VISTA (V-domain Ig Suppressor of T cell Activation), represents a critical immune checkpoint regulator that has emerged as a significant target in immunology and oncology research. This inhibitory receptor, expressed predominantly on myeloid cells and T lymphocytes, plays a central role in suppressing T cell activation and maintaining immune homeostasis. Understanding VSIR biology has become increasingly important for researchers investigating immune regulation, tumor microenvironment dynamics, and potential therapeutic interventions targeting checkpoint pathways.
This recombinant monoclonal antibody, clone 15F4, offers the consistency and reliability that demanding experimental workflows require. Because it is produced using recombinant technology with a defined sequence, you can expect exceptional lot-to-lot reproducibility throughout your research program. The human IgG1 isotype format and affinity-chromatography purification ensure high purity and specificity for detecting human VSIR.
Functional validation demonstrates robust binding activity, with the antibody showing strong interaction with immobilized human VSIR protein in ELISA format. The EC50 values of 20.84–22.73 ng/mL reflect excellent sensitivity, allowing you to work across a broad dilution range of 1:5000 to 1:50000 depending on your specific assay conditions. This flexibility enables optimization for various experimental setups while maintaining reliable detection.
The unconjugated format provides versatility for pairing with your preferred secondary detection systems. Supplied in a glycerol-based PBS buffer with Proclin 300 preservative, the antibody maintains stability when stored at -20°C or -80°C. For researchers exploring immune checkpoint biology, T cell regulation, or cardiovascular-related immune mechanisms, this antibody delivers the reproducible performance essential for generating publication-quality data.
Email: support@cusabio.com
Distributors Worldwide